Intervention Review

Metrifonate for Alzheimer's disease

  1. Jess López-Arrieta1,*,
  2. Lon Schneider2

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 20 JAN 2010

Assessed as up-to-date: 28 FEB 2008

DOI: 10.1002/14651858.CD003155.pub3

Database Title

Additional Information

How to Cite

López-Arrieta J, Schneider L. Metrifonate for Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 2. Art. No.: CD003155. DOI: 10.1002/14651858.CD003155.pub3.

Author Information

  1. 1

    Hospital Universitario La Paz-Cantoblanco, Geriatric Department, Madrid, Spain

  2. 2

    University of Southern California Keck School of Medicine, Los Angeles, CA, USA

*Jess López-Arrieta, Geriatric Department, Hospital Universitario La Paz-Cantoblanco, Ctra de Colmenar km 14,500, Madrid, 28049, Spain. pdarrieta@wanadoo.es. jlopezar.hgugm@salud.madrid.org.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 20 JAN 2010

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (61K)Standard (308K)Full (1097K)

  1. Current Version

    Metrifonate for Alzheimer's disease

    Jess López-Arrieta and Lon Schneider

    Article first published online: 20 JAN 2010 | DOI: 10.1002/14651858.CD003155.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Metrifonate for Alzheimer's disease

    JM López-Arrieta and L Schneider

    Article first published online: 25 JAN 2006 | DOI: 10.1002/14651858.CD003155.pub2

  2. Version 1

    Metrifonate for Alzheimer's disease

    JM López-Arrieta and L Schneider

    Article first published online: 30 MAY 2001 | DOI: 10.1002/14651858.CD003155

View Full Article (HTML) Summary (61K)Standard (308K)Full (1097K)